Omada Health, Inc.
$14.04
▼
-0.24%
2026-04-21 08:38:00
www.omadahealth.com
NMS: OMDA
Explore Omada Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$827.31 M
Current Price
$14.04
52W High / Low
$28.4 / $10.28
Stock P/E
—
Book Value
$3.93
Dividend Yield
—
ROCE
-5.21%
ROE
-8.68%
Face Value
—
EPS
$-0.35
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
916
Beta
—
Debt / Equity
0
Current Ratio
3.6
Quick Ratio
3.54
Forward P/E
31.82
Price / Sales
2.58
Enterprise Value
$450.02 M
EV / EBITDA
-69.44
EV / Revenue
1.73
Rating
Buy
Target Price
$21.73
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Bullfrog AI Holdings, Inc. | $0.99 | — | $18.34 M | — | -308.69% | -1.83% | $2.04 / $0.43 | $0.19 |
| 2. | Heartflow, Inc. | $31.38 | — | $2.69 B | — | -20.2% | -1.11% | $41.22 / $20.13 | $3.52 |
| 3. | LifeMD, Inc. | $5.06 | 15.69 | $242.75 M | 1.28% | -26.6% | -1.31% | $15.84 / $2.56 | $0.5 |
| 4. | Aclarion, Inc. | $3.55 | — | $7.74 M | — | -54.95% | -1.05% | $12.03 / $2.34 | $15.02 |
| 5. | Teladoc Health, Inc. | $6.1 | — | $1.09 B | — | -6.66% | -13.93% | $9.77 / $4.4 | $7.77 |
| 6. | Certara, Inc. | $6.19 | — | $989.85 M | — | 1.5% | -0.15% | $15.38 / $5.19 | $6.68 |
| 7. | Talkspace, Inc. | $5.18 | 111.06 | $865.45 M | — | 2.68% | 6.65% | $5.2 / $2.22 | $0.7 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 75.85 M | 68.03 M | 61.37 M | 54.96 M | — | — |
| Operating Profit | 3.28 M | -2.51 M | -4.34 M | -8.4 M | — | -8.52 M |
| Net Profit | 5.16 M | -3.18 M | -5.31 M | -9.45 M | — | -9.23 M |
| EPS in Rs | 0.09 | -0.05 | -0.09 | -0.16 | — | -0.16 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 260.21 M | 169.8 M | 122.78 M | 89.19 M |
| Operating Profit | -11.97 M | -43.65 M | -66 M | -72.35 M |
| Net Profit | -12.78 M | -47.14 M | -67.51 M | -72.52 M |
| EPS in Rs | -0.22 | -0.8 | -1.15 | -1.23 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 305.41 M | 150.89 M | 175.08 M | 221.8 M |
| Total Liabilities | 75.73 M | 535.29 M | 76.16 M | 66.19 M |
| Equity | 229.68 M | -384.4 M | 98.92 M | 155.6 M |
| Current Assets | 272.93 M | 113.06 M | 142.88 M | 188.56 M |
| Current Liabilities | 75.73 M | 53.95 M | 43.79 M | 34.51 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 18.25 M | -34.18 M | -49.74 M | -68.98 M |
| Investing CF | -5.83 M | -3.86 M | -2.92 M | -2.72 M |
| Financing CF | 133.22 M | -1.21 M | 0.18 M | 16.32 M |
| Free CF | 12.42 M | -38.04 M | -52.66 M | -71.7 M |
| Capex | -5.83 M | -3.86 M | -2.92 M | -2.72 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 53.24% | 38.29% | 37.67% | — |
| Earnings Growth % | 72.89% | 30.18% | 6.9% | — |
| Profit Margin % | -4.91% | -27.76% | -54.98% | -81.31% |
| Operating Margin % | -4.6% | -25.71% | -53.75% | -81.12% |
| Gross Margin % | 65.69% | 60.59% | 56.99% | 47.98% |
| EBITDA Margin % | -1.83% | -22.28% | -47.53% | -71.75% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.